That just happens to be the majority of members in the nearly 800 stock Medical-Biomed/Biotech group. But the SPDR S&P ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by ...

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...

Biotech stocks rebound after years of weakness as M&A, lower rates and easing policy fears draw investors back to the sector.

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic. Click here for ...

A fintech firm and two biotechs recently saw some huge insider buying. However, these were not the only insider purchases of ...

Cohen's Point72 purchased over 8 million shares of C4 Therapeutics within weeks of the company announcing phase 1 trial data ...

Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, ...

On July 8, Jared Holz, Mizuho, joined ‘Closing Bell Overtime’ on CNBC to discuss if the biotech sector is ready for a breakout. Jared Holz admitted that the biotech sector has been exceptionally ...

In this article, we will be taking a look at the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Mizuho’s Jared Holz appeared on CNBC’s “Closing Bell Overtime” on July 8 to talk about whether ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

Intensity Therapeutics Inc., a clinical-stage biotechnology company based in Shelton, announced this week that its ...